as 06-20-2025 3:39pm EST
Nu Skin Enterprises Inc is a health and beauty direct-selling company. It has two primary product categories: beauty products and wellness products. The company develops and distributes nutritional, weight-management products, and food supplements under the Nu Skin and Pharmanex brands, respectively. The company has operations internationally, in more than 50 countries across the Americas, Europe, and the Asia-Pacific.
Founded: | 1984 | Country: | United States |
Employees: | N/A | City: | PROVO |
Market Cap: | 361.7M | IPO Year: | 1996 |
Target Price: | $6.88 | AVG Volume (30 days): | 574.0K |
Analyst Decision: | Hold | Number of Analysts: | 2 |
Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
EPS: | -0.78 | EPS Growth: | N/A |
52 Week Low/High: | $5.32 - $12.65 | Next Earning Date: | 08-07-2025 |
Revenue: | $1,679,268,000 | Revenue Growth: | -11.85% |
Revenue Growth (this year): | -13.51% | Revenue Growth (next year): | -14.22% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
WOODBURY EDWINA D | NUS | Director | Jun 2 '25 | Sell | $8.44 | 4,532 | $38,250.08 | 42,947 | |
Battle Emma S. | NUS | Director | Jun 2 '25 | Sell | $8.44 | 4,532 | $38,250.08 | 31,006 | |
Hatchett Steven Keith | NUS | Chief Product Officer | May 28 '25 | Buy | $7.54 | 6,500 | $49,010.00 | 162,065 |
NUS Breaking Stock News: Dive into NUS Ticker-Specific Updates for Smart Investing
Simply Wall St.
4 days ago
StockStory
12 days ago
Business Wire
19 days ago
Simply Wall St.
a month ago
Simply Wall St.
a month ago
GuruFocus.com
a month ago
Associated Press Finance
a month ago
Business Wire
a month ago
The information presented on this page, "NUS Nu Skin Enterprises Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.